Medicare Part D will cover popular weight loss drugs like Wegovy and Ozempic starting in 2026, with copays capped at $50 per ...

Companies such as Novo Nordisk and Eli Lilly have plans to launch once-daily weight-loss pills in 2026, pending FDA approval, ...

The next generation of weight loss drugs will hit the market in 2026. Eli Lilly and Novo Nordisk are racing to the finish line.

And Big Pharma’s not done cashing in on the weight-loss boom. Drugmakers are readying a new wave of next-level GLP-1 treatments, with several promising candidates in the pipeline. These experimental ...

Does Weight Loss Medication Work? Key takeaways Weight loss medications work for many people. They can help those with ...

The US Food and Drug Administration (FDA) recently issued warning letters to more than 40 compounding pharmacies, demanding that they cease certain advertising practices for a variety of compounded ...

Novo Nordisk submitted a higher-dose version of semaglutide (Wegovy) to the FDA for approval as a weight-management treatment ...